Zai Lab Limited

NasdaqGM:ZLAB Stock Report

Market Cap: US$3.2b

Zai Lab Management

Management criteria checks 4/4

Zai Lab's CEO is Samantha Du, appointed in Jan 2014, has a tenure of 11.75 years. total yearly compensation is $9.08M, comprised of 9.9% salary and 90.1% bonuses, including company stock and options. directly owns 0.81% of the company’s shares, worth $26.11M. The average tenure of the management team and the board of directors is 2.8 years and 5.8 years respectively.

Key information

Samantha Du

Chief executive officer

US$9.1m

Total compensation

CEO salary percentage9.92%
CEO tenure11.8yrs
CEO ownership0.8%
Management average tenure2.8yrs
Board average tenure5.8yrs

Recent management updates

Shareholders May Not Be So Generous With Zai Lab Limited's (NASDAQ:ZLAB) CEO Compensation And Here's Why

Jun 12
Shareholders May Not Be So Generous With Zai Lab Limited's (NASDAQ:ZLAB) CEO Compensation And Here's Why

Recent updates

Is Zai Lab (NASDAQ:ZLAB) Using Debt Sensibly?

Oct 05
Is Zai Lab (NASDAQ:ZLAB) Using Debt Sensibly?

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33%

Jun 16
Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33%

Zai Lab Limited: Banking On Chinese Pharma Growth

May 22
User avatar

New VYVGART And Pipeline Advances Will Expand Global Markets

Strong revenue growth is expected due to robust product launches and pipeline innovations, with profitability anticipated through cost optimization and operational efficiencies.

Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks

Mar 20

Zai Lab Limited's (NASDAQ:ZLAB) 31% Share Price Surge Not Quite Adding Up

Mar 06
Zai Lab Limited's (NASDAQ:ZLAB) 31% Share Price Surge Not Quite Adding Up

Investors Don't See Light At End Of Zai Lab Limited's (NASDAQ:ZLAB) Tunnel

Jan 20
Investors Don't See Light At End Of Zai Lab Limited's (NASDAQ:ZLAB) Tunnel

Zai Lab: Rapidly Improving Outlook Bodes Well For The Future

Dec 26

The Zai Lab Limited (NASDAQ:ZLAB) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 15
The Zai Lab Limited (NASDAQ:ZLAB) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Zai Lab Limited (NASDAQ:ZLAB) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

Sep 28
Zai Lab Limited (NASDAQ:ZLAB) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

Zai Lab (NASDAQ:ZLAB) Has Debt But No Earnings; Should You Worry?

Sep 23
Zai Lab (NASDAQ:ZLAB) Has Debt But No Earnings; Should You Worry?

Shareholders May Not Be So Generous With Zai Lab Limited's (NASDAQ:ZLAB) CEO Compensation And Here's Why

Jun 12
Shareholders May Not Be So Generous With Zai Lab Limited's (NASDAQ:ZLAB) CEO Compensation And Here's Why

Improved Revenues Required Before Zai Lab Limited (NASDAQ:ZLAB) Stock's 50% Jump Looks Justified

May 14
Improved Revenues Required Before Zai Lab Limited (NASDAQ:ZLAB) Stock's 50% Jump Looks Justified

A Risky Bet: Zai Lab's Uncertain Future

Apr 16

Lacklustre Performance Is Driving Zai Lab Limited's (NASDAQ:ZLAB) 29% Price Drop

Mar 29
Lacklustre Performance Is Driving Zai Lab Limited's (NASDAQ:ZLAB) 29% Price Drop

We're Hopeful That Zai Lab (NASDAQ:ZLAB) Will Use Its Cash Wisely

Mar 24
We're Hopeful That Zai Lab (NASDAQ:ZLAB) Will Use Its Cash Wisely

Why Investors Shouldn't Be Surprised By Zai Lab Limited's (NASDAQ:ZLAB) Low P/S

Jan 18
Why Investors Shouldn't Be Surprised By Zai Lab Limited's (NASDAQ:ZLAB) Low P/S

Here's Why We're Not Too Worried About Zai Lab's (NASDAQ:ZLAB) Cash Burn Situation

Sep 22
Here's Why We're Not Too Worried About Zai Lab's (NASDAQ:ZLAB) Cash Burn Situation

Zai Lab Limited's (NASDAQ:ZLAB) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jun 24
Zai Lab Limited's (NASDAQ:ZLAB) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

We Think Zai Lab (NASDAQ:ZLAB) Can Afford To Drive Business Growth

Jun 02
We Think Zai Lab (NASDAQ:ZLAB) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Samantha Du's remuneration changed compared to Zai Lab's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-US$213m

Mar 31 2025n/an/a

-US$252m

Dec 31 2024US$9mUS$901k

-US$257m

Sep 30 2024n/an/a

-US$271m

Jun 30 2024n/an/a

-US$298m

Mar 31 2024n/an/a

-US$339m

Dec 31 2023US$12mUS$869k

-US$335m

Sep 30 2023n/an/a

-US$301m

Jun 30 2023n/an/a

-US$393m

Mar 31 2023n/an/a

-US$410m

Dec 31 2022US$20mUS$830k

-US$443m

Sep 30 2022n/an/a

-US$593m

Jun 30 2022n/an/a

-US$529m

Mar 31 2022n/an/a

-US$554m

Dec 31 2021US$15mUS$774k

-US$704m

Sep 30 2021n/an/a

-US$569m

Jun 30 2021n/an/a

-US$537m

Mar 31 2021n/an/a

-US$454m

Dec 31 2020US$9mUS$689k

-US$269m

Sep 30 2020n/an/a

-US$239m

Jun 30 2020n/an/a

-US$240m

Mar 31 2020n/an/a

-US$201m

Dec 31 2019US$9mUS$656k

-US$195m

Sep 30 2019n/an/a

-US$212m

Jun 30 2019n/an/a

-US$181m

Mar 31 2019n/an/a

-US$160m

Dec 31 2018US$6mUS$638k

-US$139m

Compensation vs Market: Samantha's total compensation ($USD9.08M) is about average for companies of similar size in the US market ($USD6.99M).

Compensation vs Earnings: Samantha's compensation has been consistent with company performance over the past year.


CEO

Samantha Du (59 yo)

11.8yrs
Tenure
US$9,079,948
Compensation

Dr. Ying Du, Ph D., also known as Samantha, serves as Founding Managing Director at Quan Capital. She served as Venture Partner at Sequoia Capital China.Dr. Du serves as an adjunct professor at Fudan Univ...


Leadership Team

NamePositionTenureCompensationOwnership
Ying Du
Founder11.8yrsUS$9.08m0.81%
$ 26.1m
Joshua L. Smiley
President & COO3.2yrsUS$5.47m0.078%
$ 2.5m
Rafael G. Amado
President and Head of Global Research & Development2.8yrsUS$3.65m0.038%
$ 1.2m
Yajing Chen
Chief Financial Officer2.3yrsUS$2.63m0.015%
$ 500.8k
Frazor Titus Edmondson
Chief Legal Officer & Corporate Secretary5.2yrsUS$2.75m0.038%
$ 1.2m
Christine Chiou
Senior VP & Head of Investor Relations2.4yrsno datano data
James Yan
Chief Operating Officer of R&D10.8yrsno datano data
Tong Zhu
Chief Commercial Officer of Greater China1.5yrsno datano data
Shan He
Senior VP & Chief Business Officerless than a yearno datano data
2.8yrs
Average Tenure
59yo
Average Age

Experienced Management: ZLAB's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ying Du
Founder11.8yrsUS$9.08m0.81%
$ 26.1m
Leon Moulder
Independent Director5.8yrsUS$479.73k0.065%
$ 2.1m
Peter Karl Wirth
Independent Director8.8yrsUS$482.48k0.35%
$ 11.5m
John David Diekman
Lead Independent Director8.8yrsUS$513.61k0.090%
$ 2.9m
Scott William Morrison
Independent Director4yrsUS$474.98k0.031%
$ 1.0m
Thomas F. Gajewski
Member of Oncology Scientific Advisory Boardless than a yearno datano data
William David Lis
Independent Director7yrsUS$456.11k0.032%
$ 1.0m
Lieping Chen
Member of Oncology Scientific Advisory Boardno datano datano data
Michel Vounatsos
Independent Director2.8yrsUS$472.48k0.045%
$ 1.5m
Richard Brian Gaynor
Independent Director3.9yrsUS$464.98k0.049%
$ 1.6m
Timothy A. Yap
Member of Oncology Scientific Advisory Board5.8yrsno datano data
Wing-Yu Leung
Independent Director11.8yrsno datano data
5.8yrs
Average Tenure
67yo
Average Age

Experienced Board: ZLAB's board of directors are considered experienced (5.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/22 05:08
End of Day Share Price 2025/10/22 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zai Lab Limited is covered by 29 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Li Wang WatsekCantor Fitzgerald & Co.
Louise ChenCantor Fitzgerald & Co.